A randomized, double-blind, placebo-controlled multicenter study to assess the efficacy, safety and tolerability of tegaserod 2 mg bid vs placebo in patients with chronic constipation
Phase of Trial: Phase IV
Latest Information Update: 16 Apr 2010
At a glance
- Drugs Tegaserod (Primary)
- Indications Constipation
- Focus Therapeutic Use
- 25 Dec 2007 New trial record.